Psychological disorders

Articles Cannabidiol (CBD)Neurological disorders Pain therapy Psychological disorders Tetraidrocannabinol (THC)

14 May 2024

Cannabinoids for chronic pain: when and how to use them

A Canadian working group has conducted a literature review and has drawn up clinical practice…

Dual Agenzia

Love0

Articles Cannabidiol (CBD)Neurological disorders Pain therapy Psychological disorders Tetraidrocannabinol (THC)

28 December 2023

Cannabinoids for multiple sclerosis symptoms

Some literature reviews have provided a general overview of the available data on the role…

Dual Agenzia

Love0

Articles Cannabidiol (CBD)Psychological disorders Tetraidrocannabinol (THC)

12 May 2023

The role of cannabinoids in anxiety and sleep disorders

A systematic literature review analysed the currently available evidence supporting the use of cannabinoids for…

wexa

Love0

Articles Cannabidiol (CBD)Neurological disorders Pain therapy Psychological disorders Tetraidrocannabinol (THC)

12 May 2023

Insomnia in cancer patients: the potential of cannabis

Treatment with cannabinoids for medical use could be useful to counter sleep disorders and other…

wexa

Love0

Articles Cannabidiol (CBD)Neurological disorders Pain therapy Psychological disorders Tetraidrocannabinol (THC)

3 May 2023

Cannabis and multiple sclerosis: what users think

Cannabis and multiple sclerosis: what users think A survey of Canadian multiple sclerosis patients indicated…

wexa

Love0

© 2024 Curaleaf education.
Progetto editoriale di Curaleaf International Pharma Sagl - Via Trevani, 1 - 6600 - Locarno - Svizzera
Privacy & Cookie Policy

Cannabinoids for chronic pain: when and how to use them

Cannabinoids for multiple sclerosis symptoms

The role of cannabinoids in anxiety and sleep disorders

Insomnia in cancer patients: the potential of cannabis

Cannabis and multiple sclerosis: what users think

Active ingredients

Areas of efficacy